Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 06, 2021

SELL
$15.15 - $19.78 $12.3 Million - $16.1 Million
-813,365 Closed
0 $0
Q4 2020

Feb 05, 2021

BUY
$16.86 - $19.67 $332,378 - $387,774
19,714 Added 2.48%
813,365 $15 Million
Q3 2020

Nov 06, 2020

BUY
$15.4 - $20.16 $129,945 - $170,110
8,438 Added 1.07%
793,651 $13.8 Million
Q2 2020

Aug 06, 2020

SELL
$18.24 - $21.45 $48,919 - $57,528
-2,682 Reduced 0.34%
785,213 $14.3 Million
Q1 2020

May 07, 2020

SELL
$16.28 - $25.63 $16,361 - $25,758
-1,005 Reduced 0.13%
787,895 $15.9 Million
Q4 2019

Jan 30, 2020

SELL
$19.57 - $23.52 $1.78 Million - $2.13 Million
-90,756 Reduced 10.32%
788,900 $18.4 Million
Q3 2019

Nov 12, 2019

SELL
$19.85 - $22.76 $44,702 - $51,255
-2,252 Reduced 0.26%
879,656 $17.6 Million
Q2 2019

Aug 06, 2019

BUY
$17.59 - $21.1 $39,366 - $47,221
2,238 Added 0.25%
881,908 $18.6 Million
Q1 2019

May 08, 2019

BUY
$18.01 - $20.11 $476,670 - $532,251
26,467 Added 3.1%
879,670 $17.7 Million
Q4 2018

Feb 12, 2019

SELL
$17.44 - $21.53 $2.16 Million - $2.66 Million
-123,751 Reduced 12.67%
853,203 $15.7 Million
Q3 2018

Nov 09, 2018

BUY
$19.97 - $21.96 $21,088 - $23,189
1,056 Added 0.11%
976,954 $20.9 Million
Q2 2018

Aug 08, 2018

BUY
$20.16 - $24.68 $109,388 - $133,913
5,426 Added 0.56%
975,898 $21 Million
Q1 2018

May 10, 2018

BUY
$20.31 - $24.95 $823,712 - $1.01 Million
40,557 Added 4.36%
970,472 $20.6 Million
Q4 2017

Feb 02, 2018

SELL
$20.99 - $23.89 $575,461 - $654,968
-27,416 Reduced 2.86%
929,915 $21.3 Million
Q3 2017

Nov 06, 2017

SELL
$20.07 - $21.89 $143,881 - $156,929
-7,169 Reduced 0.74%
957,331 $21 Million
Q2 2017

Aug 09, 2017

BUY
N/A
964,500
964,500 $20.4 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Todd Asset Management LLC Portfolio

Follow Todd Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Todd Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Todd Asset Management LLC with notifications on news.